Reuters logo
a month ago
BRIEF-Eli lilly reaches settlement agreement in U.S. Cialis patent litigation
July 12, 2017 / 2:10 PM / a month ago

BRIEF-Eli lilly reaches settlement agreement in U.S. Cialis patent litigation

July 12 (Reuters) - Eli Lilly And Co:

* Lilly reaches settlement agreement in U.S. Cialis patent litigation

* Says as part of agreement, Cialis exclusivity is now expected to end at earliest on September 27, 2018.

* Says ‍as part of agreement, cialis exclusivity is now expected to end at earliest on September 27, 2018.​

* Says no change to company's 2017 financial guidance or mid-term expectations through remainder of decade as a result of this settlement​

* Says there will be no change to company's 2017 financial guidance or mid-term expectations through remainder of decade as a result of this settlement

* Says patent expiration for Adcirca still expected on Nov. 21, or on May 21, 2018, if U.S. FDA grants co's application for pediatric exclusivity Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below